Published in N Engl J Med on April 10, 2008
Long-Term Results of Stenting versus Endarterectomy for Carotid-Artery Stenosis. N Engl J Med (2016) 3.74
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Restenosis after carotid artery stenting and endarterectomy: a secondary analysis of CREST, a randomised controlled trial. Lancet Neurol (2012) 3.11
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11
Open-cell versus closed-cell stent design differences in blood flow velocities after carotid stenting. J Vasc Surg (2009) 1.58
Comparison of dual-source CT angiography and MR angiography in preoperative evaluation of intra- and extracranial vessels: a pilot study. Eur Radiol (2009) 1.51
Carotid artery stenting and patient outcomes: the CABANA surveillance study. Catheter Cardiovasc Interv (2014) 1.45
Gender-specific 30-day outcomes after carotid endarterectomy and carotid artery stenting in the Society for Vascular Surgery Vascular Registry. J Vasc Surg (2013) 1.44
Carotid endarterectomy benefits patients with CKD and symptomatic high-grade stenosis. J Am Soc Nephrol (2009) 1.40
The Carotid Revascularization Endarterectomy vs. Stenting Trial completes randomization: lessons learned and anticipated results. J Vasc Surg (2009) 1.30
The diagnosis, treatment and follow-up of extracranial carotid stenosis. Dtsch Arztebl Int (2013) 1.22
Systematic Review and Meta-Analysis of Carotid Artery Stenting Versus Endarterectomy for Carotid Stenosis: A Chronological and Worldwide Study. Medicine (Baltimore) (2015) 1.00
Carotid stenting vs endarterectomy: new results in perspective. Mayo Clin Proc (2010) 0.98
Treatment of carotid artery stenosis: medical therapy, surgery, or stenting? Mayo Clin Proc (2009) 0.94
Recommendations for management of patients with carotid stenosis. Stroke Res Treat (2012) 0.87
Carotid revascularization: risks and benefits. Vasc Health Risk Manag (2014) 0.87
Medicare's policy on carotid stents limited use to hospitals meeting quality guidelines yet did not hurt disadvantaged. Health Aff (Millwood) (2011) 0.87
The interventionalism of medicine: interventional radiology, cardiology, and neuroradiology. Int Arch Med (2009) 0.86
Risk prediction for adverse events after carotid artery stenting in higher surgical risk patients. Stroke (2012) 0.86
Asymptomatic carotid stenosis: What we can learn from the next generation of randomized clinical trials. JRSM Cardiovasc Dis (2014) 0.85
Diagnostic vascular ultrasonography with the help of color Doppler and contrast-enhanced ultrasonography. Ultrasonography (2016) 0.84
A cost-effectiveness analysis of carotid artery stenting compared with endarterectomy. J Stroke Cerebrovasc Dis (2010) 0.84
The impact of Centers for Medicare and Medicaid Services high-risk criteria on outcome after carotid endarterectomy and carotid artery stenting in the SVS Vascular Registry. J Vasc Surg (2013) 0.83
Comparative effectiveness of carotid arterial stenting versus endarterectomy. J Vasc Surg (2009) 0.82
Management of carotid stenosis in women: consensus document. Neurology (2013) 0.81
Safety and efficacy assessment of carotid artery stenting in a high-risk population in a single-centre registry. Postepy Kardiol Interwencyjnej (2014) 0.81
Carotid artery stenting versus endarterectomy: a systematic review. Tex Heart Inst J (2012) 0.81
Carotid stenting versus endarterectomy in patients undergoing reintervention after prior carotid endarterectomy. J Vasc Surg (2013) 0.80
Stroke prevention-surgical and interventional approaches to carotid stenosis. Neurotherapeutics (2011) 0.79
Carotid stenting versus endarterectomy. N Engl J Med (2008) 0.79
Management of extracranial carotid artery disease. Cardiol Clin (2015) 0.78
Comparative effectiveness research: does one size fit all? Stat Med (2012) 0.78
Carotid artery stenting using a novel self-expanding braided nickel-titanium stent: feasibility and safety porcine trial. Cardiovasc Intervent Radiol (2009) 0.78
The current management of carotid atherosclerotic disease: who, when and how? Interact Cardiovasc Thorac Surg (2012) 0.78
Carotid artery stenting with distal filter protection: single-center experience in high-surgical-risk patients. Heart Vessels (2010) 0.77
Risk factors predictive of carotid artery stenting-associated subclinical microemboli. Int J Angiol (2011) 0.77
Comparison of dual protection and distal filter protection as a distal embolic protection method during carotid artery stenting: a single-center carotid artery stenting experience. Neurosurg Rev (2015) 0.77
Is age of 80 years a threshold for carotid revascularization? Curr Cardiol Rev (2011) 0.77
The early and mid-term results of carotid artery stenting in high-risk patients. J Korean Surg Soc (2011) 0.77
Hemodynamic changes and baroreflex sensitivity associated with carotid endarterectomy and carotid artery stenting. Interv Neurol (2015) 0.77
Impact of genetic polymorphisms related to clopidogrel or acetylsalicylic acid pharmacology on clinical outcome in Chinese patients with symptomatic extracranial or intracranial stenosis. Eur J Clin Pharmacol (2016) 0.76
Modulation of stroke risk in chronic kidney disease. Clin Kidney J (2015) 0.76
Clinical results of carotid artery stenting versus carotid endarterectomy. Neurosciences (Riyadh) (2016) 0.75
Intravascular Near-Infrared Spectroscopy: A Possible Tool for Optimizing the Management of Carotid Artery Disease. Int J Angiol (2015) 0.75
Comparative Review of the Treatment Methodologies of Carotid Stenosis. Int J Angiol (2015) 0.75
Evidence for management of carotid artery stenosis. Neurol Med Chir (Tokyo) (2015) 0.75
Plaque morphology detected with Duplex ultrasound before carotid angioplasty and stenting (CAS) is not a predictor of carotid artery in-stent restenosis, a case control study. BMC Neurol (2013) 0.75
Perioperative and Long-term Outcomes of Carotid Endarterectomy for Japanese Asymptomatic Cervical Carotid Artery Stenosis: A Single Institution Study. Neurol Med Chir (Tokyo) (2015) 0.75
Carotid stenting versus endarterectomy. N Engl J Med (2008) 0.75
Current concepts in the management of carotid stenosis. F1000 Med Rep (2009) 0.75
A Protocol-Based Decision for Choosing a Proper Surgical Treatment Option for Carotid Artery Stenosis. J Cerebrovasc Endovasc Neurosurg (2015) 0.75
Carotid stenting versus endarterectomy. N Engl J Med (2008) 0.75
Outcomes of carotid endarterectomy versus stenting in comparable medical risk patients. J Vasc Surg (2014) 0.75
Prognostic Factors for Neurologic Outcome in Patients with Carotid Artery Stenting. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.75
Risk factors for developing large emboli following carotid artery stenting. J Korean Neurosurg Soc (2013) 0.75
Treatment of carotid artery disease: endarterectomy or angioplasty? Curr Neurol Neurosci Rep (2011) 0.75
Carotid endarterectomy versus carotid angioplasty for stroke prevention: a systematic review and meta-analysis. J Cardiothorac Surg (2016) 0.75
Modification of a Braided Support Catheter into a Rapid Exchange System for Navigation of a Distal Protection Device through Significant Vascular Tortuosity. Interv Neuroradiol (2014) 0.75
Successful carotid stenting for chronic total occlusion of the internal carotid artery. Korean Circ J (2010) 0.75
Cerebrovascular disease: Carotid endarterectomy versus stenting-long live the king? Nat Rev Cardiol (2010) 0.75
Evidence-Based Carotid Interventions for Stroke Prevention: State-of-the-art Review. J Atheroscler Thromb (2017) 0.75
Carotid artery stenting, endarterectomy, or medical treatment alone: the debate is not over. J Tehran Heart Cent (2011) 0.75
Carotid Artery Stenting 2013: Thumbs up. Cardiol Res (2013) 0.75
Carotid endarterectomy or stenting? Heart Asia (2009) 0.75
An updated review of current concepts in the management of carotid stenosis. F1000 Med Rep (2010) 0.75
Efficacy and safety of stenting for elderly patients with severe and symptomatic carotid artery stenosis: a critical meta-analysis of randomized controlled trials. Clin Interv Aging (2015) 0.75
Creating accountable care for carotid angioplasty and stenting: A multidisciplinary carotid revascularization board. Surg Neurol Int (2012) 0.75
Stroke prevention: carotid stenting versus carotid endarterectomy. F1000 Med Rep (2010) 0.75
Carotid artery stenting using the proximal or dual protection method for near occlusion of the cervical internal carotid artery. Neurosurg Rev (2013) 0.75
Carotid artery interventions for restenosis after prior stenting: is it different from interventions of de novo lesions? Results from the carotid artery stent (CAS)--registry of the Arbeitsgemeinschaft Leitende Kardiologische Krankenhausärzte (ALKK). Clin Res Cardiol (2010) 0.75
Long-term outcome in patients with carotid artery stenting and contralateral carotid occlusion: a single neurovascular center prospective analysis. Neuroradiology (2011) 0.75
Peri-interventional neurological complication rates in patients undergoing carotid artery stenting depend on the side of the stenosis treated. Heart Vessels (2017) 0.75
In-stent restenosis after interventional treatment of carotid artery stenoses: a long-term follow-up of a single center cohort. Clin Res Cardiol (2017) 0.75
A comparison of clinical outcomes from carotid artery stenting among US hospitals. Circ Cardiovasc Qual Outcomes (2014) 0.75
Factors Influencing Decision Making for Carotid Endarterectomy versus Stenting in the Very Elderly. Front Neurol (2017) 0.75
General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation (2008) 26.42
Stenting versus endarterectomy for treatment of carotid-artery stenosis. N Engl J Med (2010) 17.57
A controlled trial of renal denervation for resistant hypertension. N Engl J Med (2014) 14.22
Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation (2007) 12.79
Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med (2004) 12.58
Twelve or 30 months of dual antiplatelet therapy after drug-eluting stents. N Engl J Med (2014) 10.54
Stenting and medical therapy for atherosclerotic renal-artery stenosis. N Engl J Med (2013) 8.91
Lifetime risk for development of atrial fibrillation: the Framingham Heart Study. Circulation (2004) 8.80
Obesity and systemic oxidative stress: clinical correlates of oxidative stress in the Framingham Study. Arterioscler Thromb Vasc Biol (2003) 7.47
Development of a risk score for atrial fibrillation (Framingham Heart Study): a community-based cohort study. Lancet (2009) 7.27
Reversing established sepsis with antagonists of endogenous high-mobility group box 1. Proc Natl Acad Sci U S A (2003) 7.14
Presentation of multivariate data for clinical use: The Framingham Study risk score functions. Stat Med (2004) 6.42
Standardized bleeding definitions for cardiovascular clinical trials: a consensus report from the Bleeding Academic Research Consortium. Circulation (2011) 6.36
Pericardial fat, visceral abdominal fat, cardiovascular disease risk factors, and vascular calcification in a community-based sample: the Framingham Heart Study. Circulation (2008) 5.95
Percutaneous repair or surgery for mitral regurgitation. N Engl J Med (2011) 5.78
Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med (2007) 5.77
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stents. N Engl J Med (2007) 5.37
The metabolic syndrome. Endocr Rev (2008) 5.33
Visceral and subcutaneous adipose tissue volumes are cross-sectionally related to markers of inflammation and oxidative stress: the Framingham Heart Study. Circulation (2007) 5.10
A risk score for predicting stroke or death in individuals with new-onset atrial fibrillation in the community: the Framingham Heart Study. JAMA (2003) 4.77
Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation (2009) 4.62
Wireless pulmonary artery haemodynamic monitoring in chronic heart failure: a randomised controlled trial. Lancet (2011) 4.59
Probable limited person-to-person transmission of highly pathogenic avian influenza A (H5N1) virus in China. Lancet (2008) 4.17
Non-inferiority trials: design concepts and issues - the encounters of academic consultants in statistics. Stat Med (2003) 4.07
Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits. PLoS Genet (2011) 3.92
Abnormal cerebral structure is present at term in premature infants. Pediatrics (2005) 3.81
Profiling the human protein-DNA interactome reveals ERK2 as a transcriptional repressor of interferon signaling. Cell (2009) 3.69
A genome-wide association study of cleft lip with and without cleft palate identifies risk variants near MAFB and ABCA4. Nat Genet (2010) 3.63
Fatty liver is associated with dyslipidemia and dysglycemia independent of visceral fat: the Framingham Heart Study. Hepatology (2010) 3.60
Association of pericardial fat, intrathoracic fat, and visceral abdominal fat with cardiovascular disease burden: the Framingham Heart Study. Eur Heart J (2009) 3.54
Comparative analysis of a large dataset indicates that internal transcribed spacer (ITS) should be incorporated into the core barcode for seed plants. Proc Natl Acad Sci U S A (2011) 3.41
Neck circumference as a novel measure of cardiometabolic risk: the Framingham Heart study. J Clin Endocrinol Metab (2010) 3.39
Standardized endpoint definitions for Transcatheter Aortic Valve Implantation clinical trials: a consensus report from the Valve Academic Research Consortium. J Am Coll Cardiol (2011) 3.37
Everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease. N Engl J Med (2010) 3.27
ST2 as a marker for risk of therapy-resistant graft-versus-host disease and death. N Engl J Med (2013) 3.27
Genetic variation in white matter hyperintensity volume in the Framingham Study. Stroke (2004) 3.13
Visceral fat is associated with lower brain volume in healthy middle-aged adults. Ann Neurol (2010) 3.05
Global profiling of the cell surface proteome of cancer cells uncovers an abundance of proteins with chaperone function. J Biol Chem (2002) 3.02
Nonemergency PCI at hospitals with or without on-site cardiac surgery. N Engl J Med (2013) 2.98
A pooled analysis of data comparing sirolimus-eluting stents with bare-metal stents. N Engl J Med (2007) 2.91
Correlates of axial gout: a cross-sectional study. J Rheumatol (2012) 2.86
Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials. Arch Neurol (2010) 2.83
Multicenter randomized controlled trial of percutaneous cryoablation versus radiofrequency ablation in hepatocellular carcinoma. Hepatology (2015) 2.81
Abdominal subcutaneous adipose tissue: a protective fat depot? Diabetes Care (2009) 2.80
Prognostic significance of gene expression profiles of metastatic neuroblastomas lacking MYCN gene amplification. J Natl Cancer Inst (2006) 2.79
Updated standardized endpoint definitions for transcatheter aortic valve implantation: the Valve Academic Research Consortium-2 consensus document. J Am Coll Cardiol (2012) 2.78
Hospital delays in reperfusion for ST-elevation myocardial infarction: implications when selecting a reperfusion strategy. Circulation (2006) 2.72
Aminotransferase levels and 20-year risk of metabolic syndrome, diabetes, and cardiovascular disease. Gastroenterology (2008) 2.70
Adiposity, cardiometabolic risk, and vitamin D status: the Framingham Heart Study. Diabetes (2009) 2.70
Allogenic mesenchymal stem cells transplantation in refractory systemic lupus erythematosus: a pilot clinical study. Ann Rheum Dis (2010) 2.64
Comparison of an everolimus-eluting stent and a paclitaxel-eluting stent in patients with coronary artery disease: a randomized trial. JAMA (2008) 2.59
Randomized trial of a distal embolic protection device during percutaneous intervention of saphenous vein aorto-coronary bypass grafts. Circulation (2002) 2.53
Inhibition of poly(ADP-ribose) polymerase enhances cell death and improves tumor growth delay in irradiated lung cancer models. Clin Cancer Res (2007) 2.52
Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial. Circ Cardiovasc Interv (2010) 2.52
Genetic correlates of brain aging on MRI and cognitive test measures: a genome-wide association and linkage analysis in the Framingham Study. BMC Med Genet (2007) 2.51
Functional proteomics identifies targets of phosphorylation by B-Raf signaling in melanoma. Mol Cell (2009) 2.50
Association of white matter hyperintensity volume with decreased cognitive functioning: the Framingham Heart Study. Arch Neurol (2006) 2.46
Nonpeptide antigens, presentation mechanisms, and immunological memory of human Vgamma2Vdelta2 T cells: discriminating friend from foe through the recognition of prenyl pyrophosphate antigens. Immunol Rev (2007) 2.46
Local, persistent activation of Rho GTPases during plasticity of single dendritic spines. Nature (2011) 2.42
Abdominal subcutaneous and visceral adipose tissue and insulin resistance in the Framingham heart study. Obesity (Silver Spring) (2010) 2.42
The Carotid Revascularization Endarterectomy versus Stenting Trial: credentialing of interventionalists and final results of lead-in phase. J Stroke Cerebrovasc Dis (2010) 2.35
A mouse to human search for plasma proteome changes associated with pancreatic tumor development. PLoS Med (2008) 2.31
Structural basis for the proinflammatory cytokine activity of high mobility group box 1. Mol Med (2003) 2.30
Defining normal distributions of coronary artery calcium in women and men (from the Framingham Heart Study). Am J Cardiol (2008) 2.26
Genetic correlates of longevity and selected age-related phenotypes: a genome-wide association study in the Framingham Study. BMC Med Genet (2007) 2.25
A genomic atlas of mouse hypothalamic development. Nat Neurosci (2010) 2.25
IFN-gamma induces high mobility group box 1 protein release partly through a TNF-dependent mechanism. J Immunol (2003) 2.24
Visceral and subcutaneous fat quality and cardiometabolic risk. JACC Cardiovasc Imaging (2013) 2.19
Functional role of CD11c+ monocytes in atherogenesis associated with hypercholesterolemia. Circulation (2009) 2.19
Epigenetic modulation of the renal β-adrenergic-WNK4 pathway in salt-sensitive hypertension. Nat Med (2011) 2.18
Adiponectin secretion is regulated by SIRT1 and the endoplasmic reticulum oxidoreductase Ero1-L alpha. Mol Cell Biol (2007) 2.17
Sirolimus-eluting stents vs vascular brachytherapy for in-stent restenosis within bare-metal stents: the SISR randomized trial. JAMA (2006) 2.16
Fatty kidney, hypertension, and chronic kidney disease: the Framingham Heart Study. Hypertension (2011) 2.13
Impact of post-intervention minimal stent area on 9-month follow-up patency of paclitaxel-eluting stents: an integrated intravascular ultrasound analysis from the TAXUS IV, V, and VI and TAXUS ATLAS Workhorse, Long Lesion, and Direct Stent Trials. JACC Cardiovasc Interv (2009) 2.12
Standardized endpoint definitions for transcatheter aortic valve implantation clinical trials: a consensus report from the Valve Academic Research Consortium. Eur Heart J (2011) 2.11
Troponin criteria for myocardial infarction after percutaneous coronary intervention. Arch Intern Med (2012) 2.09
Safety and efficacy of carotid stenting in the very elderly. Catheter Cardiovasc Interv (2010) 2.08
Elafin is a biomarker of graft-versus-host disease of the skin. Sci Transl Med (2010) 2.08
Three-year outcomes of vaginal mesh for prolapse: a randomized controlled trial. Obstet Gynecol (2013) 2.08
Cost-effectiveness of distal embolic protection for patients undergoing percutaneous intervention of saphenous vein bypass grafts: results from the SAFER trial. J Am Coll Cardiol (2004) 2.05
Markers of inflammation, metabolic risk factors, and incident heart failure in American Indians: the Strong Heart Study. J Clin Hypertens (Greenwich) (2011) 2.04
Contribution of protein fractionation to depth of analysis of the serum and plasma proteomes. J Proteome Res (2007) 2.04